Replies to post #104829 on Biotech Values

[EyeamBill]

Two positives for NVS

Briefly what are the negatives that might offset these 2 positives? I haven't read the GS report about Alcon, but I realize that acquirers are generally not treated very well by The Street in the short-term.

TIA

Bill